Jun Nakata

1.3k citations

38 papers · 402 · h-index 12

Impact in

Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Immunology
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Immunology 18
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 5
Molecular Biology 16
- Renal and related cancers 15

Co-authors: Akihiro Tsuboi (25 shared papers)Yoshitaka Oka (24 shared papers)Haruo Sugiyama (23 shared papers)Yusuke Oji (23 shared papers)Naoki Hosen (20 shared papers)Sumiyuki Nishida (20 shared papers)Fumihiro Fujiki (20 shared papers)Soyoko Morimoto (20 shared papers)
Journals: Cancer Immunology Immunotherapy (6 papers)Annals of Hematology (2 papers)Bone Marrow Transplantation (2 papers)European Journal Of Haematology (2 papers)Oncotarget (2 papers)
Partner nations: Japan Australia United States

In The Last Decade

Jun Nakata

37 papers receiving 398 citations

Peers

Countries citing papers authored by Jun Nakata

Since Specialization

Citations

This map shows the geographic impact of Jun Nakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Nakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Nakata more than expected).

Fields of papers citing papers by Jun Nakata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Nakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Nakata. The network helps show where Jun Nakata may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Nakata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Nakata Line = papers co-authored together Jun Nakata links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma Cancer Immunology Immunotherapy ·Akihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, Soyoko Morimoto, Naoki Kagawa, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Satoshi Morita, Junichi Sakamoto, Yusuke Oji, Yoshitaka Oka, Haruo Sugiyama	2018	43
2	Frequency of CD4+FOXP3+ regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD Bone Marrow Transplantation ·Tatsuya Fujioka, Hiroya Tamaki, Kazuhiro Ikegame, Satoshi Yoshihara, K Taniguchi, K Kaida, Ruri Kato, Takayuki Inoue, Jun Nakata, Shin‐ichi Ishii, Toshihiro Soma, Masaya Okada, Hiroyasu Ogawa	2012	38
3	Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy Oncology Research and Treatment ·Yoshitaka Oka, Akihiro Tsuboi, Jun Nakata, Sumiyuki Nishida, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama	2017	30
4	Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation Annals of Hematology ·Kyoko Taniguchi, Satoshi Yoshihara, Hiroya Tamaki, Tsuguto Fujimoto, Kazuhiro Ikegame, Katsuji Kaida, Jun Nakata, Takayuki Inoue, Ruri Kato, Tatsuya Fujioka, Masaya Okada, Toshihiro Soma, Hiroyasu Ogawa	2012	28
5	A Zbtb7a proto‐oncogene as a novel target for miR‐125a Molecular Carcinogenesis ·Nozomi Hojo, Naoya Tatsumi, Nahoko Moriguchi, Akihide Matsumura, Soyoko Morimoto, Jun Nakata, Fumihiro Fujiki, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshitaka Oka, Naoki Hosen, Seiji Hayashi, Haruo Sugiyama, Yusuke Oji	2015	27
6	Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning Bone Marrow Transplantation ·Satoshi Yoshihara, Kazuhiro Ikegame, K Taniguchi, K Kaida, E H Kim, Jun Nakata, Ruri Kato, Takayuki Inoue, Tatsuya Fujioka, Hiroya Tamaki, Masaya Okada, Toshihiro Soma, Hiroyasu Ogawa	2011	25
7	Syndecan-4 as a Biomarker to Predict Clinical Outcome for Glioblastoma Multiforme Treated with WT1 Peptide Vaccine Future Science OA ·S Takashima, Yoshitaka Oka, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima, Yoshiki Nakae, Jun Nakata, Sumiyuki Nishida, Naoki Hosen, Naoya Tatsumi, Kenji Mizuguchi, Naoya Hashimoto, Yusuke Oji, Akihiro Tsuboi, Atsushi Kumanogoh, Haruo Sugiyama	2016	19
8	Hemodynamic Collapse After Influenza Vaccination: A Vaccine-Induced Fulminant Myocarditis? Canadian Journal of Cardiology ·Nobutaka Nagano, Toshiyuki Yano, Yugo Fujita, Masayuki Koyama, Ryo Hasegawa, Jun Nakata, Ryo Nishikawa, Naoto Murakami, Takefumi Fujito, Atsushi Mochizuki, Hidemichi Kouzu, Atsuko Muranaka, Nobuaki Kokubu, Tetsuji Miura	2020	17
9	An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia Cancer Immunology Immunotherapy ·Natsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, Ryu Okumura, Hiroko Nakajima, Hikaru Minagawa, Soyoko Morimoto, Fumihiro Fujiki, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Kiyoshi Takeda, Akihiro Tsuboi, Keiichi Ozono	2022	14
10	Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides Oncotarget ·Jun Nakata, Hiroko Nakajima, Hiromu Hayashibara, Kanako Imafuku, Soyoko Morimoto, Fumihiro Fujiki, Daisuke Motooka, Daisuke Okuzaki, Kana Hasegawa, Naoki Hosen, Akihiro Tsuboi, Yoshitaka Oka, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama	2018	14
11	Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity Oncotarget ·Soyoko Morimoto, Fumihiro Fujiki, Kenta Kondo, Hiroko Nakajima, Yoshiki Kobayashi, Miki Inatome, Nao Aoyama, Yuya Nishida, Akihiro Tsuboi, Yoshitaka Oka, Sumiyuki Nishida, Jun Nakata, Naoki Hosen, Yusuke Oji, Haruo Sugiyama	2018	14
12	An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells PLoS ONE ·Kana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima, Naoya Tatsumi, Jun Nakata, S Takashima, Sumiyuki Nishida, Akihiro Tsuboi, Yoshitaka Oka, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama, Naoki Hosen	2015	13
13	Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms PLoS ONE ·Naoya Tatsumi, Nozomi Hojo, Hiroyuki Sakamoto, R Inaba, Nahoko Moriguchi, Keiko Matsuno, Mari Fukuda, Akihide Matsumura, Seiji Hayashi, Soyoko Morimoto, Jun Nakata, Fumihiro Fujiki, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshitaka Oka, Naoki Hosen, Haruo Sugiyama, Yusuke Oji	2015	9
14	T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy Frontiers in Immunology ·Fumihiro Fujiki, Soyoko Morimoto, Akiko Katsuhara, Akane Okuda, Saeka Ogawa, Eriko Ueda, Maki Miyazaki, Ayako Isotani, Masahito Ikawa, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshitaka Oka, Jun Nakata, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama	2022	8
15	In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity Leukemia ·Jun Nakata, K Nakano, Atsushi Okumura, Y Mizutani, Hidenori Kinoshita, Miki Iwai, Kana Hasegawa, Soyoko Morimoto, Fumihiro Fujiki, N Tatsumi, Hiroko Nakajima, Yoshiki Nakae, Sumiyuki Nishida, Akihiro Tsuboi, Yusuke Oji, Yoshitaka Oka, Haruo Sugiyama, Atsushi Kumanogoh, Naoki Hosen	2013	8
16	Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides Cancer Immunology Immunotherapy ·Fumihiro Fujiki, Akihiro Tsuboi, Soyoko Morimoto, Naoya Hashimoto, Miki Inatome, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Kana Hasegawa, Naoki Hosen, Yoshitaka Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama	2020	7
17	Imaging Assessment of Tumor Response in the Era of Immunotherapy Diagnostics ·Jun Nakata, Kayako Isohashi, Yoshitaka Oka, Hiroko Nakajima, Soyoko Morimoto, Fumihiro Fujiki, Yusuke Oji, Akihiro Tsuboi, Atsushi Kumanogoh, Naoya Hashimoto, Jun Hatazawa, Haruo Sugiyama	2021	7
18	Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients PubMed ·Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yusuke Oji, Yoshitaka Oka, Haruo Sugiyama	2016	7
19	Early detection of cytomegalovirus-specific cytotoxic T lymphocytes against cytomegalovirus antigenemia in human leukocyte antigen haploidentical hematopoietic stem cell transplantation Annals of Hematology ·Ruri Kato, Hiroya Tamaki, Kazuhiro Ikegame, Satoshi Yoshihara, Katsuji Kaida, Kyoko Taniguchi, Takayuki Inoue, Shin‐ichi Ishii, Jun Nakata, Tatsuya Fujioka, Ryoji Eguchi, Toshihiro Soma, Masaya Okada, Hiroyasu Ogawa	2015	7
20	Reader‑free ELISPOT assay for immuno‑monitoring in peptide‑based cancer vaccine immunotherapy Biomedical Reports ·Sae Hayashi, Rin Imanishi, Mayuko Adachi, Sayaka Ikejima, Jun Nakata, Soyoko Morimoto, Fumihiro Fujiki, Sumiyuki Nishida, Akihiro Tsuboi, Naoki Hosen, Hiroko Nakajima, Kana Hasegawa, Yoshitaka Oka, Haruo Sugiyama, Yusuke Oji	2020	7

About Jun Nakata

Jun Nakata is a scholar working on Immunology, Molecular Biology, Oncology, Hematology and Cardiology and Cardiovascular Medicine, having authored 38 papers that have together received 402 indexed citations. Recurring topics across this work include Renal and related cancers (15 papers), CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (13 papers), Hematopoietic Stem Cell Transplantation (8 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). The work is most often cited by research in Hematology (112 citations), Immunology (182 citations), Oncology (155 citations), Genetics (35 citations) and Molecular Biology (168 citations). Jun Nakata has collaborated with scholars based in Japan, Australia and United States. Frequent co-authors include Akihiro Tsuboi, Yoshitaka Oka, Haruo Sugiyama, Yusuke Oji, Naoki Hosen, Sumiyuki Nishida, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima and Satoshi Yoshihara. Their work appears in journals such as Cancer Immunology Immunotherapy, Annals of Hematology, Bone Marrow Transplantation, European Journal Of Haematology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Jun Nakata

Impact in

Papers in i

In The Last Decade

Jun Nakata

Peers

Countries citing papers authored by Jun Nakata

Fields of papers citing papers by Jun Nakata

All Works

About Jun Nakata

Explore authors with similar magnitude of impact

Papers in